EVP of Fin Planning, CAO Patel Mital exercised 52,781 shares at a strike of $8.21, increasing direct ownership by 1% to 230,138 units (SEC Form 4)
$RDNT
Medical Specialities
Health Care
| FORM 4 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
|||||||||||||||
| Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). | |||||||||||||||||
| Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10. | |||||||||||||||||
1. Name and Address of Reporting Person*
(Street)
|
2. Issuer Name and Ticker or Trading Symbol
RadNet, Inc. [ RDNT ] |
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
||||||||||||||||||||||||
|
3. Date of Earliest Transaction
(Month/Day/Year) 01/04/2024 | ||||||||||||||||||||||||||
|
4. If Amendment, Date of Original Filed
(Month/Day/Year) |
6. Individual or Joint/Group Filing (Check Applicable Line)
|
| Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 1. Title of Security (Instr. 3) | 2. Transaction Date (Month/Day/Year) | 2A. Deemed Execution Date, if any (Month/Day/Year) | 3. Transaction Code (Instr. 8) | 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) | 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) | 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 7. Nature of Indirect Beneficial Ownership (Instr. 4) | |||
| Code | V | Amount | (A) or (D) | Price | ||||||
| Common Stock | 01/04/2024 | M | 1,221(1) | A | (1) | 228,918 | D | |||
| Common Stock | 01/04/2025 | M | 1,220(1) | A | (1) | 230,138 | D | |||
| Common Stock | 04/04/2025 | M | 29,762 | A | $6.3 | 230,138(2) | D | |||
| Common Stock | 04/04/2025 | M | 13,681 | A | $10.05 | 230,138(3) | D | |||
| Common Stock | 04/04/2025 | M | 3,430 | A | $10.93 | 230,138(4) | D | |||
| Common Stock | 04/04/2025 | M | 3,467 | A | $20.43 | 230,138(5) | D | |||
|
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. Title of Derivative Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) | 3A. Deemed Execution Date, if any (Month/Day/Year) | 4. Transaction Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date (Month/Day/Year) | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) | ||||
| Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
| Restricted Stock Units | (1) | 01/04/2024 | M | 1,221 | (1) | (1) | Common Stock | 1,221 | $0 | 1,220 | D | ||||
| Restricted Stock Units | (1) | 01/04/2025 | M | 1,220 | (1) | (1) | Common Stock | 1,220 | $0 | 0 | D | ||||
| Employee Stock Option (right to buy) | $6.3 | 04/04/2025 | M | 29,762 | (2) | 01/06/2027 | Common Stock | 29,762 | $0 | 0 | D | ||||
| Employee Stock Option (right to buy) | $10.05 | 04/04/2025 | M | 13,681 | (3) | 01/02/2028 | Common Stock | 13,681 | $0 | 4,976 | D | ||||
| Employee Stock Option (right to buy) | $10.93 | 04/04/2025 | M | 3,430 | (4) | 01/07/2030 | Common Stock | 3,430 | $0 | 13,724 | D | ||||
| Employee Stock Option (right to buy) | $20.43 | 04/04/2025 | M | 3,467 | (5) | 01/06/2030 | Common Stock | 3,467 | $0 | 6,934 | D | ||||
| Explanation of Responses: |
| 1. On January 4, 2022, the reporting person was granted a target number of restricted stock unit ("RSU") subject to performance and time vesting. Each RSU represents a contingent right, upon vesting of the RSU, to receive one share of RadNet common stock and/or the cash equivalent of such share. 2,441 RSUs vested as to the performance vesting, and such RSUs vest in two equal annual installments on January 4, 2024 and January 4, 2025. Transaction reflects the settlement of 1,221 and 1,220 vested RSUs into shares of common stock. |
| 2. Issued in connection with retention of employment. 29,762 shares of RadNet common stock were granted on January 6, 2017. Vests 1/3 on issuance and 1/3 on each anniversary thereafter. This transaction shows the exercise of derivative securities, which was previously reported on the reporting person's Form 4 filed January 9, 2017 and is re-reporting in Table I for the avoidance of doubt. |
| 3. Issued in connection with retention of employment. 18,657 shares of RadNet common stock were granted on January 2, 2018. Vests 1/3 on issuance and 1/3 on each anniversary thereafter. This transaction shows the exercise of derivative securities, which was previously reported on the reporting person's Form 4 filed January 2, 2018 and is re-reporting in Table I for the avoidance of doubt. |
| 4. Issued in connection with retention of employment. 17,154 shares of RadNet common stock were granted on January 7, 2019. Vests 1/3 on issuance and 1/3 on each anniversary thereafter. This transaction shows the exercise of derivative securities, which was previously reported on the reporting person's Form 4 filed January 7, 2019 and is re-reporting in Table I for the avoidance of doubt. |
| 5. Issued in connection with retention of employment. 10,401 shares of RadNet common stock were granted on January 10, 2020. Vests 1/3 on issuance and 1/3 on each anniversary thereafter. This transaction shows the exercise of derivative securities, which was previously reported on the reporting person's Form 4 filed January 10, 2020 and is re-reporting in Table I for the avoidance of doubt. |
| /s/ Jose Gamez, Attorney-in-Fact | 04/08/2025 | |
| ** Signature of Reporting Person | Date | |
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
| * If the form is filed by more than one reporting person, see Instruction 4 (b)(v). | ||
| ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
| Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. | ||